276 related articles for article (PubMed ID: 16611029)
1. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells.
Efferth T
Curr Drug Targets; 2006 Apr; 7(4):407-21. PubMed ID: 16611029
[TBL] [Abstract][Full Text] [Related]
2. Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside.
Efferth T
Planta Med; 2007 Apr; 73(4):299-309. PubMed ID: 17354163
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy.
Efferth T
Drug Resist Updat; 2005; 8(1-2):85-97. PubMed ID: 15878303
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin.
Efferth T; Herrmann F; Tahrani A; Wink M
Phytomedicine; 2011 Aug; 18(11):959-69. PubMed ID: 21831619
[TBL] [Abstract][Full Text] [Related]
5. Cancer combination therapies with artemisinin-type drugs.
Efferth T
Biochem Pharmacol; 2017 Sep; 139():56-70. PubMed ID: 28366726
[TBL] [Abstract][Full Text] [Related]
6. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.
Nam W; Tak J; Ryu JK; Jung M; Yook JI; Kim HJ; Cha IH
Head Neck; 2007 Apr; 29(4):335-40. PubMed ID: 17163469
[TBL] [Abstract][Full Text] [Related]
7. [Artemisinin: a natural product for fighting against cancer].
Takatani-Nakase T
Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):61-4. PubMed ID: 24531897
[No Abstract] [Full Text] [Related]
8. Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.
Kumari K; Keshari S; Sengupta D; Sabat SC; Mishra SK
BMC Cancer; 2017 Dec; 17(1):858. PubMed ID: 29246124
[TBL] [Abstract][Full Text] [Related]
9. Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties.
Soomro S; Langenberg T; Mahringer A; Konkimalla VB; Horwedel C; Holenya P; Brand A; Cetin C; Fricker G; Dewerchin M; Carmeliet P; Conway EM; Jansen H; Efferth T
J Cell Mol Med; 2011 May; 15(5):1122-35. PubMed ID: 20629994
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activities of artemisinin and its bioactive derivatives.
Firestone GL; Sundar SN
Expert Rev Mol Med; 2009 Oct; 11():e32. PubMed ID: 19883518
[TBL] [Abstract][Full Text] [Related]
11. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
12. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid.
Ro DK; Ouellet M; Paradise EM; Burd H; Eng D; Paddon CJ; Newman JD; Keasling JD
BMC Biotechnol; 2008 Nov; 8():83. PubMed ID: 18983675
[TBL] [Abstract][Full Text] [Related]
13. Artemisinins: pharmacological actions beyond anti-malarial.
Ho WE; Peh HY; Chan TK; Wong WS
Pharmacol Ther; 2014 Apr; 142(1):126-39. PubMed ID: 24316259
[TBL] [Abstract][Full Text] [Related]
14. [Review of the use of artemisinin and its derivatives in the treatment of malaria].
Van der Meersch H
J Pharm Belg; 2005; 60(1):23-9. PubMed ID: 15828489
[TBL] [Abstract][Full Text] [Related]
15. Influence of Artemisia annua extract derivatives on proliferation, apoptosis and metastasis of osteosarcoma cells.
Tang C; Zhao Y; Huang S; Jin Y; Liu J; Luo J; Zheng J; Shi D
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):773-9. PubMed ID: 25796153
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives.
Bhaw-Luximon A; Jhurry D
Cancer Chemother Pharmacol; 2017 Mar; 79(3):451-466. PubMed ID: 28210763
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of 35 medicinal plants from Sudan towards sensitive and multidrug-resistant cancer cells.
Saeed ME; Abdelgadir H; Sugimoto Y; Khalid HE; Efferth T
J Ethnopharmacol; 2015 Nov; 174():644-58. PubMed ID: 26165828
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor activities of 4 derivatives of artemisic acid and artemisinin B in vitro].
Sun WC; Han JX; Yang WY; Deng DA; Yue XF
Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):541-3. PubMed ID: 1302444
[TBL] [Abstract][Full Text] [Related]
19. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
[TBL] [Abstract][Full Text] [Related]
20. Putative molecular determinants mediating sensitivity or resistance towards carnosic acid tumor cell responses.
Mahmoud N; Saeed MEM; Sugimoto Y; Klinger A; Fleischer E; Efferth T
Phytomedicine; 2020 Oct; 77():153271. PubMed ID: 32659679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
